CJC-1295 DAC

CJC-1295 DAC

CJC-1295 with DAC is a synthetic growth hormone-releasing hormone (GHRH) analog modified with a Drug Affinity Complex that enables albumin binding in experimental systems. This listing is for laboratory research use only. It is not a drug, food, cosmetic, or dietary supplement, and it is not approved for human or veterinary use.

Research Context

CJC-1295 with DAC appears in the scientific literature as a long-acting GHRH analog examined for prolonged GH-axis signaling. This page does not describe administration, dosing, or personal use.

Research Overview

Published work has examined this analog in controlled experimental systems of pituitary GH secretion and IGF-1-related endpoints under extended-exposure designs. Findings from those models are not established as safe or effective for people or animals, and nothing here is medical advice.

Key Research Focus Areas

• GHRH-analog structure with albumin-binding DAC modification
• Prolonged GH-axis signaling in experimental models
• Hypothalamic–pituitary feedback under extended ligand exposure
• Comparative pharmacokinetics versus non-DAC GHRH fragments

Important Disclaimer

For research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not medical advice. Handle only in a qualified research setting and in compliance with applicable law.